Korean J Hematol.  2012 Dec;47(4):239-240. 10.5045/kjh.2012.47.4.239.

Phenotypic consensus markers for plasma cell myeloma

• Hur M

• KMID: 1832098
• DOI: http://doi.org/10.5045/kjh.2012.47.4.239

Abstract

No abstract available.

MeSH Terms

Consensus
Multiple Myeloma
Plasma
Plasma Cells

Reference

1. Raja KR, Kovarova L, Hajek R. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders. Br J Haematol. 2010. 149:334–351.

2. Yuan CM, Stetler-Stevenson M. Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma. Semin Hematol. 2011. 48:32–38.

3. Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008. 93:431–438.

4. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. 1993. 81:2658–2663.

5. Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol. 1998. 152:1655–1665.

6. Kovarova L, Buresova I, Buchler T, et al. Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Neoplasma. 2009. 56:526–532.

7. Sezer O, Heider U, Zavrski I, Possinger K. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells. Haematologica. 2001. 86:837–843.

8. Jeong TD, Park CJ, Shim H, et al. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells. Korean J Hematol. 2012. 47:260–266.